Prof. Dan Peer, Ph.D.
Dalit Landesman-Milo, Ph.D.
Utilizing and developing a robust targeted delivery system of therapeutic siRNA
Meir Goldsmith, Ph.D.
Developing novel siRNA delivery systems for in vivo cancer treatment
Inbal Hazan-Halevy, Ph.D.
Nanomedicine for treating B-cells malignecies
Olga Karpov, Ph.D.
Srinivas Ramishetti, Ph.D.
Targeted delivery of siRNA therapeutics for the treatment of HIV & cancer
Manu Smriti Singh, Ph.D.
Precise engineering of versatile targeted nanoparticles for therapeutic intervention in resistant ovarian cancer
Shoshy Mizrahy, Ph.D.
Hyaluronan-coated lipid nanoparticles: physicochemical, structural and immunological considerations for optimized drug carriers
Ramesh Palakuri, Ph.D.
Synthesis of ionizable lipids and test for biological importance
Sushmita Chatterjee, Ph.D.
Evaluation of differential targets for targeted therapy of chemo-resistant ovarian cancer
Tally Levy, M.D.
Cancer stem cells in epithelial ovarian cancer
Nanoparticles for targeted drug delivery
Harnessing targeted nanotheranostics to reprogram activated leukocytes in inflammatory bowel disease
Characterization of lymphocyte derived exosomes and their potential use as drug delivery system
Harnessing RNAi nanomedicines for therapeutic gene silencing in Glioblastoma Multiforme